In May 2018, Judge M. Casey Rogers, who is overseeing the federal Abilify litigation, entered an Order to establish the “initial parameters by which the global mediation of this matter will proceed.” The parties were given 120 days (from May 1, 2018 until September 1, 2018) to finalize the framework for a mediation
Abilify
New Jersey Abilify Cases Designated As an MCL
Posted in Abilify, Defective Drugs
This month, the New Jersey Supreme Court designated the Abilify litigation in New Jersey a multicounty litigation (MCL). The Notice and Order can be found here: https://www.njcourts.gov/notices/2018/n180510b.pdf.
Though Bergen County Superior Court Judge James DeLuca had been overseeing all of the Abilify cases filed in New Jersey, those cases will now be transferred to…
New Jersey Abilify Cases: Parties Move for MCL Designation
Posted in Abilify, Defective Drugs
In November 2017, counsel for plaintiffs and defendants in the Abilify litigation in New Jersey state court moved to have the litigation designated as a multicounty litigation (MCL).
As the New Jersey judiciary site notes, a “[m]ulticounty litigation may be distinguished from other personal injury claims by several distinct features. First, multicounty litigations involve large numbers of claims that are associated with a single product. Second, despite the number of claimants, there is a commonality of factual and legal issues. Third, there is a value interdependence between the different claims.”
Currently, there are nearly 50 Abilify cases filed in Bergen County in New Jersey Superior Court, but that number is expected to rise over the next few months.…
Continue Reading New Jersey Abilify Cases: Parties Move for MCL Designation